Phase 1/2 Study of Preoperative Docetaxel and Mitoxantrone for High-Risk Prostate Cancer

Cancer - United States
doi 10.1002/cncr.24960
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Wiley

Related search

Phase II Randomized Study of Figitumumab Plus Docetaxel and Docetaxel Alone With Crossover for Metastatic Castration-Resistant Prostate Cancer

Clinical Cancer Research
Cancer ResearchOncology
2014English

Optimising Preoperative Risk Stratification Tools for Prostate Cancer Using mpMRI

European Radiology
MedicineNuclear MedicineRadiologyImaging
2017English

Treatment of Hormone-Refractory Prostate Cancer With Docetaxel or Mitoxantrone: Relationships Between Prostate-Specific Antigen, Pain, and Quality of Life Response and Survival in the TAX-327 Study

Clinical Cancer Research
Cancer ResearchOncology
2008English

Successful Phase 2 Trial of Ultrafocal Brachytherapy for Low/Intermediate Risk Prostate Cancer

International Journal of Radiation Oncology Biology Physics
OncologyRadiologyCancer ResearchRadiationNuclear MedicineImaging
2017English

Preoperative Androgen Deprivation Therapy for Localized Prostate Cancer: Delayed Biochemical Recurrence in High-Risk Disease

Clinical Genitourinary Cancer
OncologyUrology
2014English

Sunitinib Plus Androgen Deprivation and Radiation Therapy for Patients With Localized High-Risk Prostate Cancer: Results From a Multi-Institutional Phase 1 Study

International Journal of Radiation Oncology Biology Physics
OncologyRadiologyCancer ResearchRadiationNuclear MedicineImaging
2013English

A Prospective Study of Socioeconomic Status, Prostate Cancer Screening and Incidence Among Men at High Risk for Prostate Cancer

Cancer Causes and Control
Cancer ResearchOncology
2012English

A Phase I Trial of Adenovector-Mediated Delivery of Interleukin-2 (AdIL-2) in High-Risk Localized Prostate Cancer

Cancer Gene Therapy
Cancer ResearchMolecular MedicineMolecular Biology
2003English

Phase 1–2 Study of Docetaxel Plus Aflibercept in Patients With Recurrent Ovarian, Primary Peritoneal, or Fallopian Tube Cancer

The Lancet Oncology
Oncology
2011English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy